Rothschild Asset Management Inc. increased its stake in Humana Inc. (NYSE:HUM) by 27.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,112 shares of the insurance provider’s stock after buying an additional 1,100 shares during the period. Rothschild Asset Management Inc.’s holdings in Humana were worth $1,230,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. BlackRock Inc. increased its stake in Humana by 2,281.7% in the first quarter. BlackRock Inc. now owns 12,387,144 shares of the insurance provider’s stock valued at $2,553,487,000 after buying an additional 11,867,056 shares in the last quarter. Vanguard Group Inc. increased its stake in Humana by 3.6% in the first quarter. Vanguard Group Inc. now owns 9,734,767 shares of the insurance provider’s stock valued at $2,006,725,000 after buying an additional 339,620 shares in the last quarter. State Street Corp increased its stake in Humana by 1.4% in the first quarter. State Street Corp now owns 6,274,811 shares of the insurance provider’s stock valued at $1,293,487,000 after buying an additional 84,716 shares in the last quarter. FMR LLC increased its stake in Humana by 57.9% in the first quarter. FMR LLC now owns 5,050,853 shares of the insurance provider’s stock valued at $1,041,184,000 after buying an additional 1,851,197 shares in the last quarter. Finally, Renaissance Technologies LLC increased its stake in Humana by 84.3% in the first quarter. Renaissance Technologies LLC now owns 2,691,700 shares of the insurance provider’s stock valued at $554,867,000 after buying an additional 1,231,400 shares in the last quarter. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Humana Inc. (HUM) opened at 254.96 on Thursday. The company has a 50-day moving average price of $238.81 and a 200-day moving average price of $222.35. The company has a market cap of $36.85 billion, a PE ratio of 20.97 and a beta of 0.91. Humana Inc. has a 1-year low of $163.50 and a 1-year high of $255.10.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, beating the consensus estimate of $3.08 by $0.41. The company had revenue of $13.53 billion for the quarter, compared to the consensus estimate of $13.61 billion. Humana had a net margin of 3.37% and a return on equity of 15.85%. During the same period in the prior year, the firm posted $2.30 EPS. On average, analysts expect that Humana Inc. will post $11.45 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Rothschild Asset Management Inc. Buys 1,100 Shares of Humana Inc. (NYSE:HUM)” was first posted by Daily Political and is the sole property of of Daily Political. If you are reading this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be viewed at https://www.dailypolitical.com/2017/08/10/rothschild-asset-management-inc-buys-1100-shares-of-humana-inc-nysehum.html.

HUM has been the topic of several recent research reports. UBS AG restated a “neutral” rating and set a $250.00 target price (up previously from $237.00) on shares of Humana in a research report on Wednesday. Zacks Investment Research downgraded Humana from a “buy” rating to a “hold” rating in a research report on Monday, April 24th. Cowen and Company restated a “buy” rating and set a $230.00 target price on shares of Humana in a research report on Friday, July 14th. Cantor Fitzgerald restated a “neutral” rating and set a $223.00 target price (up previously from $200.00) on shares of Humana in a research report on Thursday, August 3rd. Finally, Jefferies Group LLC restated a “hold” rating and set a $257.00 target price on shares of Humana in a research report on Friday, August 4th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and twelve have issued a buy rating to the company’s stock. Humana currently has a consensus rating of “Hold” and a consensus target price of $243.65.

In related news, SVP Brian P. Leclaire sold 4,971 shares of the company’s stock in a transaction dated Wednesday, June 28th. The shares were sold at an average price of $240.00, for a total transaction of $1,193,040.00. Following the transaction, the senior vice president now directly owns 14,258 shares in the company, valued at approximately $3,421,920. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Heidi S. Margulis sold 1,500 shares of the company’s stock in a transaction dated Friday, May 26th. The shares were sold at an average price of $231.96, for a total transaction of $347,940.00. Following the transaction, the vice president now owns 8,150 shares in the company, valued at $1,890,474. The disclosure for this sale can be found here. Corporate insiders own 0.80% of the company’s stock.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.